Omeros (OMER) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.14% |
| Dec 31, 2025 | -4.95% |
| Sep 30, 2025 | 25.14% |
| Jun 30, 2025 | -28.06% |
| Mar 31, 2025 | 0.58% |
| Dec 31, 2024 | -8.19% |
| Sep 30, 2024 | -54.98% |
| Jun 30, 2024 | -58.20% |
| Mar 31, 2024 | -57.58% |
| Dec 31, 2023 | -23.20% |
| Sep 30, 2023 | -41.27% |
| Jun 30, 2023 | -31.02% |
| Mar 31, 2023 | -38.52% |
| Dec 31, 2022 | -18.41% |
| Sep 30, 2022 | -27.84% |
| Jun 30, 2022 | -32.80% |
| Mar 31, 2022 | -52.27% |
| Dec 31, 2021 | -28.25% |
| Sep 30, 2021 | -1.21% |
| Jun 30, 2021 | -28.24% |
| Mar 31, 2021 | -49.97% |
| Dec 31, 2020 | -36.71% |
| Sep 30, 2020 | -34.41% |
| Jun 30, 2020 | 20.71% |
| Mar 31, 2020 | 5.09% |
| Dec 31, 2019 | -54.59% |
| Sep 30, 2019 | -4.68% |
| Jun 30, 2019 | 3.19% |
| Mar 31, 2019 | 1.98% |
| Dec 31, 2018 | -33.83% |
| Sep 30, 2018 | -43.71% |
| Jun 30, 2018 | -34.53% |
| Mar 31, 2018 | -39.56% |
| Dec 31, 2017 | -30.24% |
| Sep 30, 2017 | -23.17% |
| Jun 30, 2017 | -32.49% |
| Mar 31, 2017 | -13.82% |
| Dec 31, 2016 | -13.03% |
| Sep 30, 2016 | -7.63% |
| Jun 30, 2016 | 10.45% |
| Mar 31, 2016 | -27.56% |
| Dec 31, 2015 | 7.61% |
| Sep 30, 2015 | -65.77% |
| Jun 30, 2015 | -78.08% |